<DOC>
	<DOCNO>NCT00755833</DOCNO>
	<brief_summary>This study conduct Europe . The aim observational study evaluate blood glucose control use NovoMix® 50 12 month initiation subject type 2 diabetes currently therapy human biphasic insulin . An additional objective also observe different regime start maintain treatment NovoMix® 50 one year .</brief_summary>
	<brief_title>Observational Study NovoMix® 50 Treatment Type 2 Diabetics 12 Months</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Type 2 diabetes treat biphasic human insulin without metformin Inadequate glycaemic control experience hypoglycaemic event would , physician 's opinion , benefit treatment NovoMix® 50 Subjects diagnose type 1 diabetes mellitus Subjects treat short act intermediate act human insulin insulin analogue Subjects unlikely comply study description , e.g . uncooperative attitude , inability come regular visit Subjects hypersensitivity biphasic insulin aspart 50 ( NovoMix® 50 ) excipients Women childbearing potential , pregnant , breastfeed intend become pregnant within next 12 month</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>